1.              Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

2.              Europe Vaccines Market – Key Takeaways

3.              Europe Vaccines Market – Market Landscape

3.1       overview

3.2       Market Segmentation

3.2.1       Europe Vaccines Market – By Technology

3.2.2       Europe Market – By Disease Indication

3.2.3       Europe Vaccines Market – By Route of Administration

3.2.4       Europe Vaccines Market – By Patient Type

3.2.5       Europe Vaccines Market – By Country

3.3       PEST Analysis

4.              Europe Vaccines Market - Key Market Dynamics

4.1       Key Market Drivers

4.1.1       Growing Awareness Programs for Vaccination in Europe

4.1.2       Increasing Vaccines Research and Development Activities in Europe.

4.2       Key Market Restraints

4.2.1       Vaccines Hesitancy in the European region.

4.3       Key Market Opportunities

4.3.1       Growing Prevalence of Infectious Diseases

4.4       Future Trends

4.4.1       New Vaccines In Development

4.5       Impact Analysis

5.              Vaccines Market – Europe Analysis

5.1       Europe Vaccines Market Revenue Forecasts and Analysis

5.2       Market Positioning

5.3       Performance of Key Players

5.3.1       Sanofi

6.              Europe Vaccines Market Analysis – By Technology

6.1       Overview

6.2       Europe Vaccines Market, By Type, 2018 & 2027 (%)

6.3       Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

6.4       Europe Recombinant Vaccines Market

6.4.1       Overview

6.4.2       Europe Recombinant Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.5       Europe Conjugate Vaccines Market

6.5.1       Overview

6.5.2       Europe Conjugate Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.6       Europe Live Attenuated Vaccines Market

6.6.1       Overview

6.6.2       Europe Live Attenuated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.7       Europe Inactivated Vaccines Market

6.7.1       Overview

6.7.2       Europe Inactivated Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

6.8       Europe Toxoid Vaccines Market

6.8.1       Overview

6.8.2       Europe Toxoid Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

7.              Europe Vaccines Market Analysis – By Disease Indication

7.1       Overview

7.2       Europe Vaccines Market, By Disease Indication, 2018 & 2027 (%)

7.3       Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

7.4       Europe DTP (Diphtheria, Tetanus, And Pertussis) Market

7.4.1       Overview

7.4.2       Europe DTP (Diphtheria, Tetanus, And Pertussis) Market Revenue and Forecast to 2027 (US$ Mn)

7.5       Europe Influenza Market

7.5.1       Overview

7.5.2       Europe Influenza Market Revenue and Forecast to 2027 (US$ Mn)

7.6       Europe Hepatitis Market

7.6.1       Overview

7.6.2       Europe Hepatitis Market Revenue and Forecast to 2027 (US$ Mn)

7.7       Europe Other Diseases Market

7.7.1       Overview

7.7.2       Europe Other Diseases Market Revenue and Forecast to 2027 (US$ Mn)

8.              Europe Vaccines Market Analysis – By Route of Administration

8.1       Overview

8.2       Europe Vaccines Market, By Route of Administration, 2018 & 2027 (%)

8.3       Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

8.4       Europe Oral Market

8.4.1       Overview

8.4.2       Europe Oral Market Revenue and Forecast to 2027 (US$ Mn)

8.5       Europe Injectable Market

8.5.1       Overview

8.5.2       Europe Injectable Market Revenue and Forecast to 2027 (US$ Mn)

8.6       Europe Other Routes of Administration Market

8.6.1       Overview

8.6.2       Europe Other Routes of Administration Market Revenue and Forecast to 2027 (US$ Mn)

9.              Europe Vaccines Market Analysis – By Patient Type

9.1       Overview

9.2       Europe Vaccines Market, By Patient Type, 2018 & 2027 (%)

9.3       Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

9.4       Europe Pediatric Market

9.4.1       Overview

9.4.2       Europe Pediatric Market Revenue and Forecast to 2027 (US$ Mn)

9.5       Europe Adults Market

9.5.1       Overview

9.5.2       Europe Adults Market Revenue and Forecast to 2027 (US$ Mn)

10.           Europe Vaccines Market Revenue And Forecasts To 2027

10.1.1     Europe Vaccines Market Revenue Overview, by Country (2017) (US$ Mn)

10.1.2     Europe Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.3     Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.4     Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.5     Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.6     Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.7     Europe Vaccines Market Revenue and Forecasts to 2027, By Country (%)

10.1.8     Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9     Germany Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.9.1  Germany Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.9.2  Germany Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.9.3  Germany Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.9.4  Germany Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.10  UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.11  UK Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.11.1 UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.11.2 UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.11.3 UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.11.4 UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.12  France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.13  France Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.13.1 France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.13.2 France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.13.3 France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.13.4 France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.14  Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.15  Italy Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.15.1 Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.15.2 Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.15.3 Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.15.4 Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

10.1.16  Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.17  Spain Vaccines Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.17.1 Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

10.1.17.2 Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

10.1.17.3 Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

10.1.17.4 Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

11.           Vaccines Market –Industry Landscape

11.1     Overview

11.2     Comparative Company Analysis

11.3     Growth Strategies Done by the Companies in the Market, (%)

11.4     Organic Developments

11.4.1     Overview

11.5     Inorganic Developments

11.5.1     Overview

12.           Vaccines Market–Key Company Profiles

12.1     Pfizer Inc.

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Financial Overview

12.1.4     Product Portfolio

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2     GlaxoSmithKline plc.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Financial Overview

12.2.4     Product Portfolio

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3     Merck & Co., Inc.

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Financial Overview

12.3.4     Product Portfolio

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4     Sanofi

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Financial Information

12.4.4     Product Portfolio

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5     Johnson & Johnson Services, Inc.

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Financial Overview

12.5.4     Product Portfolio

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6     Panacea Biotec Limited

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Financial Information

12.6.4     Product Portfolio

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7     Astellas Pharma Inc.

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Financial Overview

12.7.4     Product Portfolio

12.7.5     Swot Analysis

12.7.6     Key Developments

12.8     NOVAVAX, INC.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Financial Information

12.8.4     Product Pipeline

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9     VBI Vaccines Inc.

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Financial Information

12.9.4     Product Portfolio

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10  BAVARIAN NORDIC

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Financial Information

12.10.4  Product Pipeline

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.           Appendix

13.1     About The Insight Partners

13.2     Glossary of Terms

13.3     Methodology

13.3.1     Coverage

13.3.2     Secondary Research

13.3.3     Primary Research

LIST OF TABLES

Table 1.          Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 2.          Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 3.          Europe Vaccines Market Revenue And Forecasts to 2027, By route of administration (US$ Mn)

Table 4.          Europe Vaccines Market Revenue And Forecasts to 2027, By patient type (US$ Mn)

Table 5.          Europe Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 6.          Europe Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 7.          Europe Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

Table 8.          Europe Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

Table 9.          Germany Vaccines Market Revenue And Forecasts To 2027, By Technology (US$ Mn)

Table 10.        Germany Vaccines Market Revenue And Forecasts To 2027, By Disease Indication (US$ Mn)

Table 11.        Germany Vaccines Market Revenue And Forecasts To 2027, By Route Of Administration (US$ Mn)

Table 12.        Germany Vaccines Market Revenue And Forecasts To 2027, By Patient Type (US$ Mn)

Table 13.        UK Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 14.        UK Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 15.        UK Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

Table 16.        UK Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

Table 17.        France Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 18.        France Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 19.        France Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

Table 20.        France Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

Table 21.        Italy Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 22.        Italy Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 23.        Italy Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

Table 24.        Italy Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

Table 25.        Spain Vaccines Market Revenue And Forecasts to 2027, By Technology (US$ Mn)

Table 26.        Spain Vaccines Market Revenue And Forecasts to 2027, By Disease Indication (US$ Mn)

Table 27.        Spain Vaccines Market Revenue And Forecasts to 2027, By Route of Administration (US$ Mn)

Table 28.        Spain Vaccines Market Revenue And Forecasts to 2027, By Patient Type (US$ Mn)

Table 29.        Organic Developments Done By Companies

Table 30.        Inorganic Developments Done by Companies

Table 31.        Glossary of Terms, Vaccines market